Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000904454-21-000719
Filing Date
2021-10-22
Accepted
2021-10-22 20:03:33
Documents
2
Period of Report
2021-10-21

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 3  
1 PRIMARY DOCUMENT edgar.xml 3 1687
2 POWER OF ATTORNEY FOR UNIQURE, N.V BY RACHELLE JACQUES uniqurepoa_102021.htm EX-24 4867
  Complete submission text file 0000904454-21-000719.txt   7970
Mailing Address PAASHEUVELWEG 25A AMSTERDAM P7 1105 BP
Business Address PAASHEUVELWEG 25A AMSTERDAM P7 1105 BP 1-339-970-7000
uniQure N.V. (Issuer) CIK: 0001590560 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O CORBUS PHARMACEUTICALS HOLDINGS, INC 100 RIVER RIDGE DRIVE NORWOOD MA 02062
Business Address
Jacques Rachelle Suzanne (Reporting) CIK: 0001772610 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36294 | Film No.: 211341890